Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography. [PDF]
Shin HJ, Koo BW, Kim JN, Park JI, Na HS.
europepmc +1 more source
Aprepitant use during chemotherapy and association with survival in women with early breast cancer. [PDF]
Botteri E +10 more
europepmc +1 more source
The safety and efficacy of NEPA in preventing postoperative nausea and vomiting after general anesthesia during gastrointestinal cancer surgery: a single-center retrospective study. [PDF]
Zhang Y +6 more
europepmc +1 more source
Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer. [PDF]
Rebouças CV +4 more
europepmc +1 more source
Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. [PDF]
Wang L +8 more
europepmc +1 more source
Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study. [PDF]
Detlefsen SS +8 more
europepmc +1 more source
The efficacy of transcutaneous electrical acupoint stimulation on postoperative nausea and vomiting after laparoscopic surgery: a meta-analysis of randomized controlled trials. [PDF]
Qin S +6 more
europepmc +1 more source
International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers. [PDF]
Yakushijin K +31 more
europepmc +1 more source
Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]
Navari RM +7 more
europepmc +1 more source

